Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Patent ductus arteriosus - persisting type

Known as: DUCTUS ARTERIOSUS PATENT, PATENT DUCTUS ARTERIOSUS 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
ObjectiveTo evaluate the effectiveness of drugs used to constrict patent ductus arteriosus (PDA) in newborns < 28 weeks.MethodsWe… Expand
  • figure 1
  • table 1
  • table 2
2014
2014
OBJECTIVE To analyze the effects of treatment approach on the outcomes of newborns (birth weight [BW] < 1,000 g) with patent… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
2014
2014
OBJECTIVE To study the concurrence of congenital heart disease and hypospadias and the relationship between the two diseases… Expand
Review
2009
Review
2009
OBJECTIVE To determine risk factors associated with the presence of complications with mechanical ventilatory support (MVS) in… Expand
Review
2009
Review
2009
SUMMARY Objective: To determine risk factors associated with the presence of complications with mechanical ventilatory support… Expand
2005
2005
AIM To assess the efficacy and safety of early treatment with ibuprofen (IBU) and indomethacin (INDO) of patent ductus arteriosus… Expand
2004
2004
Minimally invasive surgical techniques have been employed successfully for a wide spectrum of cardiothoracic procedures. These… Expand
Review
1997
Review
1997
OBJECTIVE Pediatric video-assisted thoracic surgery closure of patent ductus arteriosus can now be performed on a routine basis… Expand
  • table 1
  • table 2
1987
1987
The effect of patent ductus arteriosus (PDA) and its therapy on the pharmacokinetic disposition of gentamicin in very low birth… Expand
1975
1975